| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.02B | 9.98B | 11.51B | 10.44B | 9.05B | 6.83B |
| Gross Profit | 7.06B | 7.03B | 6.93B | 6.77B | 6.38B | 4.88B |
| EBITDA | 5.42B | 5.48B | 5.31B | 5.30B | 5.02B | 3.84B |
| Net Income | 3.15B | 3.18B | 4.38B | 3.06B | 2.90B | 2.06B |
Balance Sheet | ||||||
| Total Assets | 22.44B | 22.63B | 22.52B | 21.15B | 19.34B | 14.86B |
| Cash, Cash Equivalents and Short-Term Investments | 18.43B | 17.95B | 18.34B | 17.02B | 15.77B | 11.38B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.39B | 5.26B | 6.52B | 6.97B | 7.18B | 4.79B |
| Stockholders Equity | 17.05B | 17.36B | 16.00B | 14.15B | 12.14B | 10.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.79B | 1.84B | 2.28B | 5.19B | 4.39B |
| Operating Cash Flow | 0.00 | 2.82B | 2.83B | 3.15B | 6.17B | 5.22B |
| Investing Cash Flow | 0.00 | -1.11B | 1.01B | -867.00M | -978.00M | -830.00M |
| Financing Cash Flow | 0.00 | -2.10B | -2.54B | -1.05B | -810.00M | -671.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥74.56B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
72 Outperform | ¥49.93B | 23.84 | ― | 1.50% | 13.48% | 35.63% | |
70 Outperform | ¥93.27B | 18.51 | ― | 1.02% | 26.47% | 142.77% | |
68 Neutral | ¥75.36B | 22.94 | ― | 1.42% | -6.04% | -24.88% | |
64 Neutral | ¥50.11B | 48.80 | ― | 0.20% | 50.53% | 227.57% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥40.68B | 106.87 | ― | ― | 29.56% | 86.66% |